Page 3 - Drug Manufacturers

Lupin recieves USFDA nod to market generic anthelmintic tablets

According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said

Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study

According to the study, baricitinib also helped reduce the quantity of the novel coronavirus in infected cells

Chennai-based start-up developing Covid-19 remedy, plans to test in US

Patent application filed in India, firm hopes to bring product out in three years

AstraZeneca, Gilead merger likely to hit political, strategic hurdles

Political opposition from both the UK and the US could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak, Citigroup said

Remdesivir pricing in India likely to be lower than global rate: Sources

Indian companies await clarity from the drug regulator on animal toxicology study before they can launch here

Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business

The company has registered 10% growth in revenues at Rs 4,431.8 cr for the quarter under review from Rs 4,016.6 cr in the year-ago period

Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April

Coronavirus: UP govt reopens 5,200 industrial units during lockdown

905 flour mills, 419 oil mills and 235 pulses mills were currently functional in the state so that there is no shortage of essential food items

Coronavirus outbreak: Pharma market grows 9% in March due to panic buying

Cardio-diabetic and respiratory segments clock robust growth

Coronavirus: ITC repurposes Himachal perfume plant to produce sanitisers

The move follows ITC temporarily stopping manufacture of cigarettes - its main revenue earner - as well as production of non essential items

Govt allows doorstep delivery of drugs to help citizens under lockdown

The health ministry invoked section 26B of the Drugs and Cosmetics Act, 1940 to facilitate the doorstep delivery of drugs to consumers

Govt approves Rs 13K-crore package to boost bulk drugs manufacture

Industry feels India first needs to tap existing capacity before setting up new drugs parks

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

Demand for chronic illness medicines rising faster than acute drugs: Report

Long-term treatments like diabetes, high blood pressure and lipid-lowering drugs are classified into the chronic category

Govt reviews industry's demands to implement changes in drug price policy

A senior government official said the industry has been requesting for an amendment to allow them to implement the price change from the next batch.

PharmEasy, 1mg, Netmeds look to power their brands, build trust in business

According to many reports, e-pharmacies have spent well over their capacities in building their brands

Indian pharmaceutical companies spread business to avoid regulatory ire

Increased USFDA import alerts could be reason for finding alternative sites

Restart unannounced inspections of drug units in India, China: US senator

The chairman of the Senate Finance Committee said this was needed as these facilities provided most of the ingredients for production inside the US

Active pharmaceutical ingredients focus helps drug firms offset slowdown

Besides captive consumption, the company also supplies APIs to external customers across international markets

As price pressure mounts, pharma companies tap analytics to cut costs

Cipla is the first company in the Asia Pacific to upgrade to a cloud-based pharmacovigilance solution